(Q44465329)

3 December 2017

title

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609. (English)

1 reference

3 December 2017

main subject

metastatic breast cancer

1 reference

1 reference

1 reference

3

Norikazu Masuda

1 reference

3 December 2017

Tetsuya Taguchi

1

1 reference

3 December 2017

Daigo Yamamoto

2

1 reference

3 December 2017

Koji Oba

4

1 reference

3 December 2017

Takahiro Nakayama

5

1 reference

3 December 2017

Takuya Nagata

6

1 reference

3 December 2017

Masaya Nomura

7

1 reference

3 December 2017

Katsuhide Yoshidome

8

1 reference

3 December 2017

Hiroshi Yoshino

9

1 reference

3 December 2017

Nobuki Matsunami

10

1 reference

3 December 2017

Masaru Miyashita

11

1 reference

3 December 2017

Yoshihiko Furuya

12

1 reference

3 December 2017

Takanori Ishida

13

1 reference

3 December 2017

Kazuyuki Wakita

14

1 reference

3 December 2017

Junichi Sakamoto

15

1 reference

3 December 2017

Shinzaburo Noguchi

16

1 reference

3 December 2017

Kinki Breast Cancer Study Group (KBCSG)

17

1 reference

3 December 2017

publication date

20 January 2013

1 reference

Cancer Chemotherapy and Pharmacology

3 December 2017

published in

1 reference

3 December 2017

volume

71

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

741-747

1 reference

Extending survival with chemotherapy in metastatic breast cancer

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Survival, quality of life and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Study of low-dose capecitabine monotherapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Potential predictive factors for response to weekly paclitaxel treatment in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Adjuvant chemotherapy in older women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2068-7

10.1007/S00280-012-2068-7

21 January 2018

Identifiers

DOI

1 reference

release_nlwejvmklnac5pxu2lbgutbkai

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nlwejvmklnac5pxu2lbgutbkai

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference